Taysha Gene Therapies (TSHA) PT Lowered to $15 at Truist Securities, Keeps 'Buy' Following Strategic Deal
Tweet Send to a Friend
Truist Securities analyst Joon Lee lowered the price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
